ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,321.58
-0.89%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Prothena Corporation PLC (PRTA)

  7. Prothena Corporation PLC (PRTA) Noticias

PRTA Prothena Corporation PLC

22.93
0.89 (4.04%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Prothena Corporation PLC PRTA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.89 4.04% 22.93 23:00:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
22.99 22.74 23.70 22.93 22.04
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202415:05BWProthena to Report First Quarter 2024 Financial Results on..
15/4/202415:05BWProthena Announces Review on Birtamimab Mechanism of Action..
05/3/202420:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202420:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/3/202415:05BWProthena to Participate in Upcoming Healthcare Conferences
04/3/202415:05BWProthena Appoints David Ford to Newly Created Chief People..
29/2/202420:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202420:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202420:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202420:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202420:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202420:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:29EDGAR2Form S-3ASR - Automatic shelf registration statement of..
22/2/202415:56EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/2/202415:06EDGAR2Form 8-K - Current report
21/2/202415:05BWProthena Announces Appointment of Daniel G. Welch as..
15/2/202415:09EDGAR2Form 8-K - Current report
15/2/202415:05BWProthena Reports Fourth Quarter and Full Year 2023 Financial..
14/2/202411:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202418:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202415:05BWProthena to Report Fourth Quarter and Full Year 2023..
24/1/202418:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:06EDGAR2Form 144 - Report of proposed sale of securities
08/1/202407:35EDGAR2Form 8-K - Current report
08/1/202407:30BWProthena Provides Updates on PRX012, PRX123, Birtamimab and..
20/12/202318:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:03EDGAR2Form 144 - Report of proposed sale of securities
30/11/202317:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202315:05EDGAR2Form 144 - Report of proposed sale of securities
02/11/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202315:09EDGAR2Form 8-K - Current report
02/11/202315:05BWProthena Reports Third Quarter 2023 Financial Results and..
26/10/202315:05BWProthena to Report Third Quarter 2023 Financial Results on..
25/10/202319:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202315:01EDGAR2Form 144 - Report of proposed sale of securities
11/10/202319:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202315:02EDGAR2Form 144 - Report of proposed sale of securities
04/10/202318:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202315:03EDGAR2Form 144 - Report of proposed sale of securities
27/9/202319:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202315:01EDGAR2Form 144 - Report of proposed sale of securities
25/9/202315:56EDGAR2Form 144 - Report of proposed sale of securities
19/9/202316:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202315:51EDGAR2Form 144 - Report of proposed sale of securities
13/9/202318:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202318:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202315:33EDGAR2Form 144 - Report of proposed sale of securities
13/9/202315:01EDGAR2Form 144 - Report of proposed sale of securities
06/9/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
PRTA
Prothena
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados